Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M W DeGregorioV J Wiebe

Abstract

Triphenylethylene compounds, such as tamoxifen, have shown chemosensitizing activity independent of estrogen receptor status in doxorubicin-resistant cells. We examined the chemosensitizing activity of a new triphenylethylene, toremifene, and its major metabolites in a doxorubicin-resistant human breast cell line, MCF-7/DOX. In addition, we examined the chemosensitizing activity of unbound plasma toremifene and its metabolites isolated from patients treated with toremifene doses of 20 to 400 mg/d. MCF-7/DOX cells were exposed to ultrafiltrate plasma specimens in the absence and presence of doxorubicin. These latter studies were single-blinded. Toremifene and its major metabolites were capable of sensitizing multidrug-resistant cells to doxorubicin. The degree of chemosensitizing activity in vitro correlated with the plasma concentrations of toremifene and its metabolites (P less than .05). Plasma samples isolated from patients receiving high-dose toremifene (400 mg/d) had the greatest chemosensitizing activity. We present evidence that toremifene and its metabolites can sensitize resistant MCF-7/DOX cells to doxorubicin, that this effect is concentration-dependent, and that sensitizing activity can be detected at clinically ach...Continue Reading

Citations

Jan 1, 1993·Cancer Chemotherapy and Pharmacology·G T WurzV J Wiebe
Nov 4, 1996·International Journal of Cancer. Journal International Du Cancer·R De VincenzoS Mancuso
Jun 27, 2013·Journal of Cheminformatics·Lazaros Mavridis, John Bo Mitchell
Feb 11, 2014·International Journal of Cancer. Journal International Du Cancer·Gregory T Wurz, M W DeGregorio
Jul 1, 1991·Journal of Veterinary Internal Medicine·J Stewart, N T Gorman
May 1, 1990·Japanese Journal of Cancer Research : Gann·T WatanabeK Abe
Jan 1, 1994·Breast Cancer Research and Treatment·S K KoesterM W DeGregorio
Jan 1, 1994·Investigational New Drugs·N H Patel, M L Rothenberg
Nov 1, 1991·Journal of the American Geriatrics Society·L BalducciG H Lyman
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·R GrenmanH Joensuu
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·J U MaenpaaM W DeGregorio
Aug 1, 1990·Breast Cancer Research and Treatment·L Kangas
Jan 1, 1993·Cytotechnology·J M Ford, W N Hait
Jul 5, 2005·Expert Opinion on Investigational Drugs·J Robert
Nov 13, 2009·Photochemistry and Photobiology·Arménio SerraMaria Filomena Botelho
Feb 27, 2001·Japanese Journal of Cancer Research : Gann·H MinamiY Sasaki
Aug 1, 1990·Breast Cancer Research and Treatment·P C KohlerD C Tormey
Jun 1, 1995·Clinical Pharmacology and Therapeutics·M AnttilaE A Sotaniemi
Jul 13, 2012·The Cochrane Database of Systematic Reviews·Chen MaoJin Ling Tang
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M Ford

Related Concepts

Blood
Cell Density
Cell Division Phases
High Pressure Liquid Chromatography Procedure
Dose-Response Relationship, Drug
Adriamycin
Drug Resistance
Drug Augmentation
Zitazonium
Ultrafiltration

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.